- Home
- ORGN vs STRO Comparison
ORGN vs STRO Comparison
Compare ORGN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGN
- STRO
- Stock Information
- Founded
- ORGN 2008
- STRO 2003
- Country
- ORGN United States
- STRO United States
- Employees
- ORGN N/A
- STRO N/A
- Industry
- ORGN Major Chemicals
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORGN Industrials
- STRO Health Care
- Exchange
- ORGN Nasdaq
- STRO Nasdaq
- Market Cap
- ORGN 72.7M
- STRO 77.7M
- IPO Year
- ORGN N/A
- STRO 2018
- Fundamental
- Price
- ORGN $0.43
- STRO $0.80
- Analyst Decision
- ORGN Strong Buy
- STRO Hold
- Analyst Count
- ORGN 1
- STRO 7
- Target Price
- ORGN $3.00
- STRO $3.97
- AVG Volume (30 Days)
- ORGN 854.9K
- STRO 833.9K
- Earning Date
- ORGN 08-13-2025
- STRO 08-12-2025
- Dividend Yield
- ORGN N/A
- STRO N/A
- EPS Growth
- ORGN N/A
- STRO N/A
- EPS
- ORGN N/A
- STRO N/A
- Revenue
- ORGN $29,887,000.00
- STRO $66,434,000.00
- Revenue This Year
- ORGN $49.18
- STRO N/A
- Revenue Next Year
- ORGN $144.81
- STRO N/A
- P/E Ratio
- ORGN N/A
- STRO N/A
- Revenue Growth
- ORGN N/A
- STRO N/A
- 52 Week Low
- ORGN $0.40
- STRO $0.52
- 52 Week High
- ORGN $1.90
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- ORGN 38.07
- STRO 46.11
- Support Level
- ORGN $0.42
- STRO $0.76
- Resistance Level
- ORGN $0.47
- STRO $0.94
- Average True Range (ATR)
- ORGN 0.03
- STRO 0.07
- MACD
- ORGN 0.01
- STRO -0.01
- Stochastic Oscillator
- ORGN 24.20
- STRO 29.11
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.